Facilitating virus entry |
BPV |
E6 facilitates the BPV entry by clathrin interaction |
[35] |
|
Antiapoptotic effect |
HPV |
E6 promotes Bax degradation, resulting in an antiapoptotic effect |
[114, 115] |
|
Binding to E6AP ubiquitin ligase |
HPV |
E6 expressed in E. coli and insects binds to E6AP ubiquitin ligase |
[50, 95, 116, 117] |
|
Binding to DNA |
HPV |
E6 expressed in E. coli binds with DNA |
[118–120] |
|
Cell immortalization |
HPV |
E6 promotes p53 degradation and cell immortalization |
[121–123] |
|
Epigenetic downregulation of p53 |
HPV |
E6 expressed in baculovirus induces hypoacetylation of p53 |
[124, 125] |
HPV |
E6 expressed in E. coli interacts with p300/CBP, reducing p53 levels |
[126] |
BPV |
E6 interacts with p300/CBP, reducing p53 levels |
[51] |
|
Disruption of mitotic apparatus |
HPV |
E6 transfected using LXSN vectors |
[29, 30, 127] |
|
Malignant transformation in cell culture |
HPV |
Complete genome of HPV-16 transfected in NIH 3T3 cells |
[45, 88, 128–130] |
|
Interaction with paxillin |
BPV |
E6 of BPV-1 interacts with paxillin, reducing the focal adhesion |
[34, 69, 72, 131, 132] |
|
Repressor activity of telomerases |
HPV |
E6 induces the hTERT expression, reducing the telomerase activity |
[96, 133, 134] |
|
Immune depletion |
HPV |
E6 expressed in yeast reduces the levels of interferon regulatory factor-3 |
[135] |